Oxford BioDynamics (STU:LMQ) Change In Receivables : €-0.51 Mil (TTM As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Oxford BioDynamics Change In Receivables?

Oxford BioDynamics's change in receivables for the quarter that ended in Sep. 2024 was €-0.49 Mil. It means Oxford BioDynamics's Accounts Receivable increased by €0.49 Mil from Mar. 2024 to Sep. 2024 .

Oxford BioDynamics's change in receivables for the fiscal year that ended in Sep. 2024 was €-0.51 Mil. It means Oxford BioDynamics's Accounts Receivable increased by €0.51 Mil from Sep. 2023 to Sep. 2024 .

Oxford BioDynamics's Accounts Receivable for the quarter that ended in Sep. 2024 was €0.16 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Oxford BioDynamics's Days Sales Outstanding for the six months ended in Sep. 2024 was 77.86.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Oxford BioDynamics's liquidation value for the six months ended in Sep. 2024 was €-5.56 Mil.

Oxford BioDynamics Change In Receivables Historical Data

The historical data trend for Oxford BioDynamics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Change In Receivables Chart

Oxford BioDynamics Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Change In Receivables

Get a 7-Day Free Trial

0.15

-0.65

0.54

-0.52

-0.51

Oxford BioDynamics Semi-Annual Data
	Sep14	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Change In Receivables	Get a 7-Day Free Trial															-0.07	-0.34	-0.18	-0.02	-0.49

Oxford BioDynamics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.51 Mil.

Oxford BioDynamics (STU:LMQ) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Oxford BioDynamics's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.157	/	0.368	*	91
=	77.86

2. In Ben Graham's calculation of liquidation value, Oxford BioDynamics's accounts receivable are only considered to be worth 75% of book value:

Oxford BioDynamics's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3.369	-	9.236	+	0.75 * 0.157	+	0.5 * 0.383
=	-5.56

Oxford BioDynamics Change In Receivables Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioDynamics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Oxford BioDynamics PLC (STU:LMQ) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

OXBOF:USA OBD:UK LMQ:Germany

Address

John Smith Drive, 3140 Rowan Place, ARC Oxford, Oxford, GBR, OX4 2WB

Website

https://www.oxfordbiodynamics.com

Oxford BioDynamics PLC is a biotechnology company engaged in developing and commercializing precision clinical diagnostic tests for life-changing diseases. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The tests are based on the company's proprietary 3D genomic biomarker platform, EpiSwitch which enables screening, evaluation, validation, and monitoring of biomarkers. In addition, the company offers, EpiSwitch Explorer Array Kit for 3D genome profiling. It is also developing new tests in the areas of oncology, neurology, inflammation, hepatology, and animal health. Geographically, it derives key revenue from the United States of America.

Oxford BioDynamics Headlines

No Headlines